Tag:
Revance Therapeutics
Latest Headlines
Latest Headlines
Medicis inks $104M licensing pact for botox therapy
Medicis Pharmaceutical agreed to pay Revance Therapeutics $10 million upfront and up to $94 million in milestones for worldwide licensing rights to a preclinical botox therapy that may help erase
